Use for topsentin compounds and pharmaceutical compositions cont
Use of Δ5-androstene-3β-ol-7,17-dione in the...
Use of α-1AR subtype-selective drugs in patients with...
Use of α-glucosidase inhibitors to treat alphavirus...
Use of α-phenylthiocarboxylic and...
Use of β-adrenoceptor antagonists for the manufacture...
Use of γ-tocopherol and its oxidative metabolite...
Use of &agr;-alkylglucosides and &agr;-alkylglucoside esters...
Use of &agr;-linolenic acid metabolites for treatment or...
Use of &agr;-methyl-p-tyrosine to inhibit melanin production...
Use of &agr;1&bgr;1 integrin receptor inhibitors and...
Use of &agr;1-adrenoreceptor antagonists in the prevention...
Use of &agr;1A adrenoceptor agonists with &agr;1B and...
Use of &agr;1C specific compounds to treat benign prostatic...
Use of &bgr;-lactamase inhibitors as neuroprotectants
Use of &Dgr;5-androstene-3&bgr;-OL7,17-dione in the...
Use of &Dgr;5-androstene-3&bgr;ol-7,17-dione in the...
Use of &ggr;-tocopherol and its oxidative metabolite...
Use of &ggr;-tocopherol and its oxidative metabolite...
Use of &ggr;-tocopherol and its oxidative metabolite...